The combinational treatment of irradiation and quercetin in the human ovarian cancer xenograft model could restrict tumor growth while activating p53, γ-H2AX and CCAAT/enhancer-binding protein homologous protein [91]. The gene discussed is TP53; the disease is ovarian cancer.